Collaboration to focus on prostate cancer research

Vancouver, BC – The Centre for Drug Research and Development (CDRD) and the Vancouver Prostate Centre (VPC) have signed a collaboration agreement to work together on the discovery, development and commercialization of anti-cancer therapeutics.

“Knowing that our two organizations hold similar mandates, this collaboration with CDRD ensures that we are maximizing our resources to increase cancer research efforts and creating viable paths of commercialization for locally developed therapeutics,” said Dr Martin Gleave, executive director of the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver General Hospital (VGH) Centre of Excellence.

“While we have worked with the Vancouver Prostate Centre in the past, the formalization of this collaboration allows us to seek and initiate specific projects that will benefit from our combined, complementary strengths,” said Natalie Dakers, CEO at CDRD.

The two organizations are working together on an international collaboration with Griffith University’s Eskitis Institute in Queensland, Australia.